BH
Bei Hu
Levine Cancer Institute, University of Texas MD Anderson Cancer Center, University of California San Francisco, University of California Los Angeles, Vanderbilt University
0000-0002-4325-0929
Employment
-
Levine Cancer Institute Physician2017 - Present
-
University of Texas MD Anderson Cancer Center Fellow2014 - 2017
-
Vanderbilt University Intern/Resident Physician2011 - 2014
Education
-
University of California San Francisco MD2007 - 2011
-
University of California Los Angeles BS2003 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- The MAGNOLIA Trial: Zanubrutinib, a Next-Generation Bruton Tyrosine Kinase Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Marginal Zone Lymphoma. Save
- Equal access to care and nurse navigation leads to equitable outcomes for minorities with aggressive large B-cell lymphoma. Save
- Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation. Save
- Rituximab, lenalidomide, and ibrutinib in relapsed/refractory primary cutaneous diffuse large B-cell lymphoma, leg type. Save
- A Malignant Electrocardiogram. Save
- Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients. Save
- De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era. Save
- Standardizing Opioid Prescribing Practices for Cancer-Related Pain Via a Novel Interactive Documentation Template at a Public Hospital. Save
- A Tale of Two Eras: The Story of Autologous Stem Cell Transplantation with and without Thiotepa for Primary Central Nervous System Lymphoma Save
- Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction Save